Prevalence of Intrauterine Adhesions After D&C With or Without Antiadhesion Gel After Abortion in Second Trimester. (ADAB)
Primary Purpose
Asherman Syndrome, Abortion Late
Status
Unknown status
Phase
Phase 4
Locations
Study Type
Interventional
Intervention
Hyaluronic Acid 20 MG/ML Injectable Solution
Dilation and curretage
Sponsored by
About this trial
This is an interventional prevention trial for Asherman Syndrome focused on measuring Asherman Syndrome, Abortion Late, Hyaluronic acid gel, Hysteroscopy
Eligibility Criteria
Inclusion Criteria:
- Adult (18 to 40 years) women with a wish for future pregnancy
- abortion in the 2nd trimester of pregnancy (over 12 weeks of pregnancy) with instrumental revision of the uterine cavity (RCUI)
- signed informed consent
Exclusion Criteria:
- age below 18 years, age over 40 years
- history of previous uterine surgery (myomectomy, resection of the intrauterine septum, disruption of intrauterine adhesions)
- suspected molar pregnancy
- signs of pelvic infection
- disagreement with participation in the study
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Hyaluronic acid gel after D&C
Only D&C
Arm Description
After abortion in the II trimester, we provide D&C and after the procedure, we apply in uterine cavity Hyaluronic acid gel.
After abortion, in the II trimester, we provide only D&C.
Outcomes
Primary Outcome Measures
Prevalence of Intrauterine adhesions after D&C and intrauterine application of hyaluronic acid gell.
To find out wheter the application of antiadhesive agent with hyaluronic acid has an effect on the frequency of intrauterine adhesions after this procedure.
Prevalence of Intrauterine adhesions after D&C.
Dermination of the frequency of intrauterine adhesions in women who underwent instrumental revision of the uterine cavity (RCUI, revisio cavi uteri instrumentalis) after abortion in the 2nd trimester of pregnancy
Secondary Outcome Measures
Pregnancy rate
Number of pregnancies (pregnancy rate) in the period of 24 months after RCUI in both groups
Delivery rate
Number of term deliveries in the 24 months after RCUI in both groups
Full Information
NCT ID
NCT04671914
First Posted
December 10, 2020
Last Updated
January 12, 2021
Sponsor
Institute for the Care of Mother and Child, Prague, Czech Republic
Collaborators
Bulovka Hospital, General University Hospital, Prague
1. Study Identification
Unique Protocol Identification Number
NCT04671914
Brief Title
Prevalence of Intrauterine Adhesions After D&C With or Without Antiadhesion Gel After Abortion in Second Trimester.
Acronym
ADAB
Official Title
Prevalence of Intrauterine Adhesions After the Application of Hyaluronic Acid Gel After Dilatation and Curettage in Women With Spontaneous Abortion or Induction of Abortion From 12+0 Till 23+6 Week of Pregnancy.
Study Type
Interventional
2. Study Status
Record Verification Date
January 2021
Overall Recruitment Status
Unknown status
Study Start Date
February 1, 2021 (Anticipated)
Primary Completion Date
December 31, 2022 (Anticipated)
Study Completion Date
June 1, 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Institute for the Care of Mother and Child, Prague, Czech Republic
Collaborators
Bulovka Hospital, General University Hospital, Prague
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Only patients who sign an informed consent will be included. Patients after a miscarriage in the 2nd trimester of pregnancy who need to perform an instrumental revision of the uterine cavity (RCUI, revisio cavi uteri instrumentalis) will be randomized into two groups. In the first group, RCUI will be performed according to current standards. In the second group, an anti-adhesive preparation with hyaluronic acid (Hyalobarrier gel Endo) will be applied to the uterine cavity at the end of the RCUI procedure. Eight to twelve weeks after the operation, the occurrence of adhesions will be evaluated by ultrasound examination and diagnostic hysteroscopy (if adhesions will be detected, they will be disrupted). The study will also include the completion of a questionnaire in terms of the frequency and strength of the menstrual cycle. The presence of adhesions will be assessed according to The American Fertility Society (AFS).
Detailed Description
Methodology Only patients who sign informed consent will be included. Patients after a miscarriage in the 2nd trimester of pregnancy who need to perform an instrumental revision of the uterine cavity (RCUI, revisio cavi uteri instrumentalis) will be randomized into two groups. In the first group, RCUI will be performed according to current standards. In the second group, an anti-adhesive preparation with hyaluronic acid (Hyalobarrier gel Endo) will be applied to the uterine cavity at the end of the RCUI procedure. Eight to twelve weeks after the operation, the occurrence of adhesions will be evaluated by ultrasound examination and diagnostic hysteroscopy (if adhesions will be detected, they will be disrupted). The study will also include the completion of a questionnaire in terms of the frequency and strength of the menstrual cycle. The presence of adhesions will be assessed according to The American Fertility Society (AFS).
Expected number of enrolled subjects: a total of 200 patients, 100 in each branch Entry criteria: Adult (18 to 40 years old) women with a wish for future pregnancy, abortion in the 2nd trimester of pregnancy (over 12 weeks of pregnancy) with instrumental revision of the uterine cavity (RCUI), signed informed consent
Exclusion criteria: age below 18 years, age over 40 years, history of previous uterine surgery (myomectomy, resection of the intrauterine septum, disruption of intrauterine adhesions), suspicion of molar pregnancy, signs of pelvic infection, disagreement with participation in the study
Primary goals of the project:
determination of the frequency of intrauterine adhesions in women who underwent instrumental revision of the uterine cavity (RCUI, revisio cavi uteri instrumentalis) after abortion in the 2nd trimester of pregnancy
to determine whether the application of an antiadhesive agent with hyaluronic acid has an effect on the frequency of intrauterine adhesions after this procedure
A similar prospective randomized multicenter study investigating the relationship of intrauterine adhesions using an intrauterine gel with hyaluronic acid was published in 2017 by Hooker. Patients were enrolled in the study up to the 14th week of pregnancy. The incidence of intrauterine adhesions was statistically lower in the hyaluronic acid group compared to the no treatment group (13% vs. 30.6%, RR 0.43, 95% CI 0.22-0.83, p 0.013). However, this study investigated RCUI in the first trimester of pregnancy. Our study is to our knowledge the first with a focus on the second trimester RCUI.
Secondary goals of the project:
number of pregnancies (pregnancy rate) in the period of 24 months after RCUI in both groups
number of term pregnancies in the 24 months after RCUI in both groups
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Asherman Syndrome, Abortion Late
Keywords
Asherman Syndrome, Abortion Late, Hyaluronic acid gel, Hysteroscopy
7. Study Design
Primary Purpose
Prevention
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Model Description
Multicenter prospective controlled study
Masking
ParticipantInvestigator
Masking Description
Participant will not be informed about usage of hyalobarier gel or not. Care provider - at the time of RCUI the surgeon will know from randomisation if apply the gel or not. The investigator performing evaluation of adhesions by hysteroscopy will be blinded to the arm which the participants belong to.
Allocation
Randomized
Enrollment
200 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Hyaluronic acid gel after D&C
Arm Type
Active Comparator
Arm Description
After abortion in the II trimester, we provide D&C and after the procedure, we apply in uterine cavity Hyaluronic acid gel.
Arm Title
Only D&C
Arm Type
Active Comparator
Arm Description
After abortion, in the II trimester, we provide only D&C.
Intervention Type
Drug
Intervention Name(s)
Hyaluronic Acid 20 MG/ML Injectable Solution
Intervention Description
Application of hyaluronic acid gel into uterine cavity after After abortion in II trimester we do D&C
Intervention Type
Other
Intervention Name(s)
Dilation and curretage
Intervention Description
After abortion in II trimester we do D&C.
Primary Outcome Measure Information:
Title
Prevalence of Intrauterine adhesions after D&C and intrauterine application of hyaluronic acid gell.
Description
To find out wheter the application of antiadhesive agent with hyaluronic acid has an effect on the frequency of intrauterine adhesions after this procedure.
Time Frame
3 month
Title
Prevalence of Intrauterine adhesions after D&C.
Description
Dermination of the frequency of intrauterine adhesions in women who underwent instrumental revision of the uterine cavity (RCUI, revisio cavi uteri instrumentalis) after abortion in the 2nd trimester of pregnancy
Time Frame
3 month
Secondary Outcome Measure Information:
Title
Pregnancy rate
Description
Number of pregnancies (pregnancy rate) in the period of 24 months after RCUI in both groups
Time Frame
24 month
Title
Delivery rate
Description
Number of term deliveries in the 24 months after RCUI in both groups
Time Frame
24 month
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Adult (18 to 40 years) women with a wish for future pregnancy
abortion in the 2nd trimester of pregnancy (over 12 weeks of pregnancy) with instrumental revision of the uterine cavity (RCUI)
signed informed consent
Exclusion Criteria:
age below 18 years, age over 40 years
history of previous uterine surgery (myomectomy, resection of the intrauterine septum, disruption of intrauterine adhesions)
suspected molar pregnancy
signs of pelvic infection
disagreement with participation in the study
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Jiri Hanacek, MD, Ph.D.
Phone
+420604154736
Email
jiri.hanacek@upmd.eu
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
12620443
Citation
Wang X, Chen C, Wang L, Chen D, Guang W, French J. Conception, early pregnancy loss, and time to clinical pregnancy: a population-based prospective study. Fertil Steril. 2003 Mar;79(3):577-84. doi: 10.1016/s0015-0282(02)04694-0.
Results Reference
result
PubMed Identifier
16905025
Citation
Rai R, Regan L. Recurrent miscarriage. Lancet. 2006 Aug 12;368(9535):601-11. doi: 10.1016/S0140-6736(06)69204-0.
Results Reference
result
PubMed Identifier
18902559
Citation
ASHERMAN JG. Amenorrhoea traumatica (atretica). J Obstet Gynaecol Br Emp. 1948 Feb;55(1):23-30. doi: 10.1111/j.1471-0528.1948.tb07045.x. No abstract available.
Results Reference
result
PubMed Identifier
28390688
Citation
Hooker AB, de Leeuw R, van de Ven PM, Bakkum EA, Thurkow AL, Vogel NEA, van Vliet HAAM, Bongers MY, Emanuel MH, Verdonkschot AEM, Brolmann HAM, Huirne JAF. Prevalence of intrauterine adhesions after the application of hyaluronic acid gel after dilatation and curettage in women with at least one previous curettage: short-term outcomes of a multicenter, prospective randomized controlled trial. Fertil Steril. 2017 May;107(5):1223-1231.e3. doi: 10.1016/j.fertnstert.2017.02.113. Epub 2017 Apr 6.
Results Reference
result
Learn more about this trial
Prevalence of Intrauterine Adhesions After D&C With or Without Antiadhesion Gel After Abortion in Second Trimester.
We'll reach out to this number within 24 hrs